Literature DB >> 11695888

Phenylalanine 393 exerts thermodynamic control over the heme of flavocytochrome P450 BM3.

T W Ost1, C S Miles, A W Munro, J Murdoch, G A Reid, S K Chapman.   

Abstract

Site-directed mutants of the phylogenetically conserved phenylalanine residue F393 were constructed in flavocytochrome P450 BM3 from Bacillus megaterium. The high degree of conservation of this residue in the P450 superfamily and its proximity to the heme (and its ligand Cys400) infers an essential role in P450 activity. Extensive kinetic and thermodynamic characterization of mutant enzymes F393A, F393H, and F393Y highlighted significant differences from wild-type P450 BM3. All enzymes expressed to high levels and contained their full complement of heme. While the reduction and subsequent treatment of the mutant P450s with carbon monoxide led to the formation of the characteristic P450 spectra in all cases, the absolute position of the Soret absorption varied across the series WT/F393Y (449 nm), F393H (445 nm), and F393A (444 nm). Steady-state turnover rates with both laurate and arachidonate showed the trend WT > F393Y >> F393H > F393A. Conversely, the trend in the pre-steady-state flavin-to-heme electron transfer was the reverse of the steady-state scenario, with rates varying F393A > F393H >> F393Y approximately wild-type. These data are consistent with the more positive substrate-free [-312 mV (F393A), -332 mV (F393H)] and substrate-bound [-151 mV (F393A), -176 mV (F393H)] reduction potentials of F393A and F393H heme domains, favoring the stabilization of the ferrous-form in the mutant P450s relative to wild-type. Elevation of the heme iron reduction potential in the F393A and F393H mutants facilitates faster electron transfer to the heme. This results in a decrease in the driving force for oxygen reduction by the ferrous heme iron, so explaining lower overall turnover of the mutant P450s. We postulate that the nature of the residue at position 393 is important in controlling the delicate equilibrium observed in P450s, whereby a tradeoff is established between the rate of heme reduction and the rate at which the ferrous heme can bind and, subsequently, reduce molecular oxygen.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11695888     DOI: 10.1021/bi010716m

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  31 in total

1.  Insights into an efficient light-driven hybrid P450 BM3 enzyme from crystallographic, spectroscopic and biochemical studies.

Authors:  Jessica Spradlin; Diana Lee; Sruthi Mahadevan; Mavish Mahomed; Lawrence Tang; Quan Lam; Alexander Colbert; Oliver S Shafaat; David Goodin; Marco Kloos; Mallory Kato; Lionel E Cheruzel
Journal:  Biochim Biophys Acta       Date:  2016-09-14

Review 2.  Spectroscopic studies of the cytochrome P450 reaction mechanisms.

Authors:  Piotr J Mak; Ilia G Denisov
Journal:  Biochim Biophys Acta Proteins Proteom       Date:  2017-06-28       Impact factor: 3.036

3.  Role of the Proximal Cysteine Hydrogen Bonding Interaction in Cytochrome P450 2B4 Studied by Cryoreduction, Electron Paramagnetic Resonance, and Electron-Nuclear Double Resonance Spectroscopy.

Authors:  Roman Davydov; Sangchoul Im; Muralidharan Shanmugam; William A Gunderson; Naw May Pearl; Brian M Hoffman; Lucy Waskell
Journal:  Biochemistry       Date:  2016-02-03       Impact factor: 3.162

4.  Cryo-EM reveals the architecture of the dimeric cytochrome P450 CYP102A1 enzyme and conformational changes required for redox partner recognition.

Authors:  Min Su; Sumita Chakraborty; Yoichi Osawa; Haoming Zhang
Journal:  J Biol Chem       Date:  2020-01-03       Impact factor: 5.157

5.  Structural motif-based homology modeling of CYP27A1 and site-directed mutational analyses affecting vitamin D hydroxylation.

Authors:  David E Prosser; Yuding Guo; Zongchao Jia; Glenville Jones
Journal:  Biophys J       Date:  2006-02-24       Impact factor: 4.033

6.  Characterization of active site structure in CYP121. A cytochrome P450 essential for viability of Mycobacterium tuberculosis H37Rv.

Authors:  Kirsty J McLean; Paul Carroll; D Geraint Lewis; Adrian J Dunford; Harriet E Seward; Rajasekhar Neeli; Myles R Cheesman; Laurent Marsollier; Philip Douglas; W Ewen Smith; Ida Rosenkrands; Stewart T Cole; David Leys; Tanya Parish; Andrew W Munro
Journal:  J Biol Chem       Date:  2008-09-24       Impact factor: 5.157

7.  Stabilization and characterization of a heme-oxy reaction intermediate in inducible nitric-oxide synthase.

Authors:  Jesús Tejero; Ashis Biswas; Zhi-Qiang Wang; Richard C Page; Mohammad Mahfuzul Haque; Craig Hemann; Jay L Zweier; Saurav Misra; Dennis J Stuehr
Journal:  J Biol Chem       Date:  2008-09-24       Impact factor: 5.157

8.  A panel of cytochrome P450 BM3 variants to produce drug metabolites and diversify lead compounds.

Authors:  Andrew M Sawayama; Michael M Y Chen; Palaniappan Kulanthaivel; Ming-Shang Kuo; Horst Hemmerle; Frances H Arnold
Journal:  Chemistry       Date:  2009-11-02       Impact factor: 5.236

9.  Role of arginine guanidinium moiety in nitric-oxide synthase mechanism of oxygen activation.

Authors:  Claire Giroud; Magali Moreau; Tony A Mattioli; Véronique Balland; Jean-Luc Boucher; Yun Xu-Li; Dennis J Stuehr; Jérôme Santolini
Journal:  J Biol Chem       Date:  2009-11-30       Impact factor: 5.157

Review 10.  Oxygen activation by cytochrome P450 monooxygenase.

Authors:  Djemel Hamdane; Haoming Zhang; Paul Hollenberg
Journal:  Photosynth Res       Date:  2008-07-04       Impact factor: 3.573

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.